ADVFN US – Market Content Editor
-

Cipher Digital Shares Fall 12% After Announcing $850 Million Convertible Debt Offering
Cipher Digital Inc. (NASDAQ:CIFR) shares declined 12% on Tuesday after the company announced plans to raise $850 million through a private offering of zero-interest convertible senior notes due in 2032, alongside a proposed exchange of existing debt for common stock. The financing is intended to support development of the company’s Barber Lake project, expansion of…
-

Raytheon Secures $729 Million in Counter-Drone Contracts for US Army, Qatar and Jordan
Raytheon, a subsidiary of RTX Corporation (NYSE:RTX), has secured contracts worth $729 million to supply counter-drone defence systems to the US Army, Qatar and Jordan, marking the first international sales of two of its key technologies. The agreements cover components of the Low, Slow, Small Unmanned Aircraft Integrated Defeat System (LIDS), which is designed to…
-

Citigroup Beats Third-Quarter Earnings Estimates as Revenue Reaches Highest Q3 Level in a Decade
Citigroup Inc. (NYSE:C) reported third-quarter 2026 earnings and revenue above Wall Street expectations on Tuesday, supported by growth across its Services, Markets, Banking and Wealth businesses. The US banking group posted earnings of $2.85 per diluted share, exceeding the analyst consensus of $2.65. Revenue increased 8% year on year to $23.85 billion, compared with $22.1…
-

Domino’s Pizza Beats Third-Quarter Earnings Estimates but Shares Fall as Same-Store Sales Growth Slows
Domino’s Pizza, Inc. (NASDAQ:DPZ) reported third-quarter 2026 earnings and revenue above Wall Street expectations on Tuesday, although modest same-store sales growth in the United States and international markets weighed on investor sentiment. The pizza restaurant operator posted adjusted earnings per share of $4.60, exceeding the analyst consensus of $4.36 by $0.24. Revenue increased 3.4% year…
-

Wells Fargo Beats Third-Quarter Profit Estimates as Loan Growth and Improved Efficiency Support Earnings
Wells Fargo & Co. (NYSE:WFC) reported third-quarter 2026 earnings above Wall Street expectations on Tuesday, supported by higher lending volumes, increased deposits and improved operating efficiency, although revenue fell short of analyst forecasts. The US banking group posted net income of $6.0 billion, equivalent to $1.87 per diluted share, exceeding the consensus earnings estimate of…
-

Johnson & Johnson Beats Third-Quarter Earnings Estimates and Raises 2026 Revenue and Profit Outlook
Johnson & Johnson (NYSE:JNJ) reported third-quarter 2026 earnings and revenue above Wall Street expectations on Tuesday, supported by growth in its Innovative Medicine business and continued expansion across its medical technology operations. The US healthcare company posted adjusted earnings per share of $2.59, exceeding the analyst consensus of $2.53 by $0.06. Revenue increased 5.9% year…
-

JPMorgan Chase Misses Third-Quarter Earnings Estimates as Fixed-Income Trading Revenue Declines
JPMorgan Chase (NYSE:JPM) reported third-quarter 2026 earnings below Wall Street expectations, as weaker fixed-income trading revenue and investment securities losses weighed on the largest US bank’s financial performance. The bank posted net income of $15.31 billion, equivalent to $5.57 per share, for the quarter ended 30 September. Analysts surveyed by Bloomberg had expected earnings of…
-

Goldman Sachs Beats Third-Quarter Earnings Estimates as Equities Trading Revenue Surges 72%
Goldman Sachs Group Inc. (NYSE:GS) reported third-quarter 2026 earnings and revenue above Wall Street expectations on Tuesday, supported by strong equities trading activity and increased investment banking fees. The US investment bank posted adjusted earnings per share of $17.01, exceeding analysts’ consensus forecast of $13.09 by $3.92. Revenue rose 23% year on year to $18.68…
-

BioNTech Shares Fall 5% as BNT113 Cancer Trial Misses Progression-Free Survival Endpoint
BioNTech (NASDAQ:BNTX) shares declined 5% on Tuesday after the biotechnology company reported that its investigational mRNA cancer therapy, BNT113, failed to meet an initial primary endpoint in a clinical trial involving patients with advanced human papillomavirus (HPV)-associated head and neck cancer. The study evaluated BNT113 in combination with pembrolizumab, an established immunotherapy treatment, to determine…
-

Albertsons Beats Second-Quarter Earnings Estimates but Withdraws 2026 Guidance Amid Business Review
Albertsons Companies, Inc. (NYSE:ACI) reported second-quarter fiscal 2026 adjusted earnings above analyst expectations, although declining comparable sales and weaker profitability prompted the US grocery retailer to withdraw its full-year financial outlook. The company posted adjusted earnings per share of $0.36, exceeding the consensus estimate of $0.33 by $0.03. Revenue totalled $18.89 billion, matching market forecasts…